- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06401759
Use of Podcasts in the Education of Hypertension Patients
Use of Podcasts in the Education of Hypertension Patients: A Randomized Controlled Study
Hypertension is an important public health problem all over the world due to its high prevalence and its association with increased risk of cardiovascular disease. At the same time, it is a condition in which acquired factors, genetic and metabolic disorders, characterized by increased intra-arterial blood pressure, occur together . According to the World Health Organization, hypertension is defined as systolic blood pressure of 140 mmHg and diastolic blood pressure of 90 mmHg or above According to the Arterial Hypertension Management 2018 Implementation Guide of the European Society of Cardiology and the European Society of Hypertension, it is estimated that there are more than 1 billion hypertension patients in the world and this number will reach 1.5 billion by 2025. In our country, there are approximately 20 million individuals with hypertension. It is thought to be Hypertension treatment is a lifelong process that includes lifestyle changes and patient education along with medical treatment.Turkish Endocrinology and Metabolism.
The aim of hypertension treatment is to ensure that blood pressure decreases to the targeted level, to minimize target organ damage and complications caused by hypertension, to eliminate symptoms and reduce drug side effects, to ensure patient compliance with treatment and to provide self-management skills by enabling the patient to take an active role in his own treatment. The concept of self-management; It includes providing individuals with knowledge and skills regarding disease management, providing support to maintain the individual's self-care, supporting the decision-making process, and helping to recognize and cope with problems. The main goal in hypertension treatment is to control the patient's blood pressure. Achieving and maintaining self-management is also one of the most effective factors in controlling blood pressure. Inadequately treated and low self-management In hypertension patients, blood pressure control is inadequate and health risks increase. Therefore, all strategies implemented to increase self-management in hypertension patients also have positive effects on the individual's blood pressure control and disease prognosis.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Center
-
Elâzığ, Center, Turkey (Türkiye), 25240
- Fırat university
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Education level must be at least primary school level.
- Patients with or without treatment experience
- Being between the ages of 18 and 65
- Being diagnosed with hypertension at least 6 months ago
- Being using at least one hypertensive drug
- Having enough internet to listen to podcasts on Spotify
- Have Spotify supported devices (iOS 14 or above, Android OS 5.0 or above, OS X 10.15 or above, Windows 10 or above)
- Being competent in using a mobile phone
- Having 18.64 points and above in e-health literacy assessment
Exclusion Criteria:
- Those who have physical (speech, hearing impairment, etc.), neurological and psychological problems that prevent them from filling out research forms and participating in training.
- Those who do not have sufficient equipment (mobile phone or computer with internet connection) for podcast training
- Intervention group patients who do not listen to podcasts on Spotify (patients who do not fill out verbally or Google forms (Diary))
- Patients in the control group who were understood to have logged in to their account on Spotify and listened to podcasts.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
|
|
|
Experimental: Podcast
|
Routine maintenance will be applied.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hill Bone Hypertension Treatment Compliance Scale
Time Frame: Before and 12 weeks after application
|
Measures treatment compliance of hypertension patients.
was developed for evaluation.
The Cronbach's Alpha value of the scale was found to be between 0.74 and 0.84.
The scale is a 4-point Likert type and consists of 14 items and 3 sub-dimensions.
The subscales of the scale are Interview (6th, 7th and 8th Questions), Medical (1st, 2nd, 9th, 10th, 11th, 12th, 13th and 14th Questions) and Nutrition (3rd, 14th Questions).
4th and 5th Questions).
Question 6 on the scale is reverse coded.
The total score range on the scale varies between 0 and 42.
If the person gives the most positive answers to all questions and receives a total of 0 points, he or she is considered fully compliant.
Scores outside zero indicate the degree of non-compliance.
Since the questions are in the negative type of questions, the compliance decreases as the score increases.
|
Before and 12 weeks after application
|
|
Self-Care Management Scale in Chronic Diseases
Time Frame: Before and 12 weeks after application
|
It was developed to evaluate self-care management in chronic diseases.
(The scale has a 5-point Likert structure (1=strongly disagree, 2=disagree, 3=undecided, 4=agree, 5=strongly agree) and consists of 35 items.
The scale consists of two sub-dimensions.
These sub-dimensions are: "self-protection" ( articles 2, 6, 8, 11, 15, 18, 19, 20, 22, 23, 25-34), and "social protection" (articles 1, 3, 4, 5, 7, 9, 10, 12, 13 , 14, 16, 17, 21, 24 and 35 items.
The 3rd, 15th, 19th and 28th items in the scale are negative expressions.
The total scores that can be obtained from the scale vary between 35 and 175 points.
It indicates that the individual's self-care management also increases
|
Before and 12 weeks after application
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024/04-47
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
Clinical Trials on Podcast
-
University of PennsylvaniaCompleted
-
Necmettin Erbakan UniversityCompleted
-
Vanderbilt University Medical CenterRecruiting
-
University of the West of EnglandC&R Research, Inc.; Unilever R&DRecruitingBody ImageUnited States
-
Sinem CeylanNot yet recruitingPain | Stress | Anxiety | ColposcopyTurkey
-
University of South CarolinaCompleted
-
Gamze BULUTNot yet recruitingNursing Education | Preoperative Care | Evidence Based Nursing | Podcast
-
Arizona State UniversityMayo ClinicCompleted
-
Necmettin Erbakan UniversityCompletedSatisfaction | Waste ManagementTurkey (Türkiye)
-
Istanbul University - CerrahpasaEnrolling by invitation